Autoimmune glomerulonephritis in a multiple sclerosis patient after cladribine treatment.

Kristina SchönfelderHelene SchuhFrederick PfisterJulia KrämerUte EisenbergerJelena SkuljecJana HackertTobias RuckSteffen PfeufferMichael FleischerAnja GäcklerTim HagenackerAndreas KribbenSven G MeuthChristoph KleinschnitzRefik Pul

Published in: Multiple sclerosis (Houndmills, Basingstoke, England) (2021)

Neurologists should be attentive to the development of secondary autoimmunity in cladribine-treated patients.

Keyphrases

multiple sclerosis
newly diagnosed
end stage renal disease
ejection fraction
prognostic factors
patient reported outcomes
patient reported
celiac disease